Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)

Description

The Hispanic/Latinx community (hereafter Hispanic) is the country's second-largest racial/ethnic group, accounting for 19.1% of the total population. However, they remain one of the most underserved populations with suboptimal access to healthcare and screening services due to low income, lack of health insurance, perceived discrimination, language barriers, and limited health literacy. Lung cancer is the leading cause of cancer related mortality with 1.8 million annual deaths worldwide, with Hispanic patients known to have lower survival rates compared with non-Hispanic whites. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases this mortality rate of lung cancer by 20%. Yet many Latinx patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test and compare the effect of a multi-level intervention on ordering LDCT within 4 months after patient enrollment to those in an Enhanced Usual Care. Our proposed intervention includes: * Primary care provider notifications of patients' LCS eligibility; * Patients' education; * Patients' referral to financial navigation resources; * Patients' reminder to discuss LCS during primary care provider (PCP) visit.

Conditions

Lung Cancer

Study Overview

Study Details

Study overview

The Hispanic/Latinx community (hereafter Hispanic) is the country's second-largest racial/ethnic group, accounting for 19.1% of the total population. However, they remain one of the most underserved populations with suboptimal access to healthcare and screening services due to low income, lack of health insurance, perceived discrimination, language barriers, and limited health literacy. Lung cancer is the leading cause of cancer related mortality with 1.8 million annual deaths worldwide, with Hispanic patients known to have lower survival rates compared with non-Hispanic whites. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases this mortality rate of lung cancer by 20%. Yet many Latinx patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test and compare the effect of a multi-level intervention on ordering LDCT within 4 months after patient enrollment to those in an Enhanced Usual Care. Our proposed intervention includes: * Primary care provider notifications of patients' LCS eligibility; * Patients' education; * Patients' referral to financial navigation resources; * Patients' reminder to discuss LCS during primary care provider (PCP) visit.

Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)

Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)

Condition
Lung Cancer
Intervention / Treatment

-

Contacts and Locations

Anaheim

UCI Health Family Health Center - Anaheim, Anaheim, California, United States, 92801

Orange

UCI Health SeniorHealth Center -Pavillion 4, Orange, California, United States, 92868

Orange

UCI Medical Center, Pavilion 3, Orange, California, United States, 92868

Santa Ana

UCI Health Family Health Center - Santa Ana, Santa Ana, California, United States, 92701

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Aged 50- 80 years of age.
  • * Be able to speak English and Spanish
  • * Must have a scheduled appointment with their Primary Care Providers within next one to three months.
  • * The Scheduled PCP appointment is at any of the 4 University of California Irvine Health (UCI Health) primary care clinics in Orange County including two UCI federally qualified health centers
  • * History of 20-pack year smoking history ( based on survey self-report)
  • * Current smoker or a former smoker who has quit smoking within the last 15 years (based on survey self-report)
  • * Prior history of lung cancer
  • * Chest CT for any reason in the last 12 months based on self-report and UCI EMR
  • * History of Alzheimer\'s disease or dementia

Ages Eligible for Study

50 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of California, Irvine,

Gelareh Sadigh, MD, PRINCIPAL_INVESTIGATOR, University of California, Irvine

Study Record Dates

2024-12